Pancreatitis
Questions Received:
Responses:
What is acute pancreatitis and what causes this?
12th April 1999
The pancreas has two important roles - one is to produce digestive enzymes that are passed into the digestive tract through a duct, and the other is to release hormones into the blood to control sugar levels. So the pancreas is both an exocrine and an endocrine gland. The pancreatic enzymes can become a danger to the pancreas itself if they become activated within the pancreatic tissues, and this is what happens in pancreatitis. The enzymes begin to digest the cells of the pancreas. Pancreatitis is an inflammatory process that produces different degrees of oedema, haemorrhage, and the destruction of pancreatic cells. It can be very serious. Acute pancreatitis means that the inflammation has suddenly appeared, whereas chronic pancreatitis means a more gradual process over a longer period of time. Pancreatitis is more common in adults than in children.
There are several possible causes:
Disease of the biliary tract, for example: gall stones blocking the duct where it opens into the duodenum
Alcoholism
Trauma - bullet or knife wound
Duodenal ulcer
Hyperparathyroidism - over active parathyroid glands
Hyperlipidaemia - abnormally high levels of lipids such as cholesterol in the blood
Viral infection
Certain drugs such as corticosteroids and thiazide diuretics.

< Diagram showing the pancreas, liver, duodenum, and stomach. The gall bladder and bile ducts are shown in green, the portal vein and tributaries in blue, and the abdominal aorta and branches in red.
What are the symtoms of pancreatitis, and how long does it usually last? Does the procedure, endoscopic retrograde cholangiopancreatography give you acute pancreatitis? My blood count for this test for the pancreas was over 37 thousand. Please tell me anything you can, I have to have the procedure again in a week.
20th April 1999
The main symptom of pancreatitis is severe abdominal pain that is sudden in onset and continuous. It is usually felt in the midline just below the ribs, but may be biased to one side or the other depending on which part of the pancreas is most affected. The pain often radiates to the back, and the affected person may obtain some relief by sitting forward and holding the knees. However, analgesia is generally required. Nausea and vomiting often accompany the pain. The pain is usually severe for the first day and then decreases over following days as the inflammation subsides. Clinical examination may reveal a degree of shock, increased heart rate, increased white blood cell count and fever. The serum levels of amylase and other pancreatic enzymes may rise to five times their normal values during the first 24 to 72 hours - presumably the blood count you mention was for one of these enzymes.
The procedure you mention, endoscopic retrograde cholangiopancreatography (ERCP), is known to trigger acute pancreatitis in some patients (eg: Solana de Lope et al, 1998; Maldonado et al, 1999). One possible reason is that during the procedure a small quantity of bile might enter the pancreatic duct and irritate it. Under normal physiological conditions this does not occur, because even though the biliary system of the liver and the pancreatic duct share a final common pathway into the duodenum, the secretion pressure of the pancreas is generally somewhat higher than the biliary pressure in the common bile duct, and thus the pancreas is protected from bile reflux. During the ERCP procedure, however, reflux might be induced. As a minimally invasive and cost-effective procedure, ERCP has established itself as a valuable tool for the detection and treatment of a variety of biliary tract disorders (Schmalz and Geenen, 1999; Sahai et al, 1999). Thus any associated risks have to be weighed up in relation to potential benefits. It is also of course possible that pancreatitis that occurs after an ERCP might be caused by the clinical problem that warranted the use of the procedure in the first place, for example gallstones, and not necessarily by the use of the procedure itself. Alternatives to ERCP are being developed, including non-invasive magnetic resonance cholangiopancreatography, but so far the results and usefulness have been less satisfactory than ERCP (Shimizu et al, 1999).
References
Maldonado, M.E., Brady, P.G., Mamel, J.J., and Robinson, B. (1999) Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). American Journal of Gastroenterology, 94(2), 387-390 (Feb).
Sahai, A.V., Mauldin, P.D., Marsi, V., Hawes, R.H., and Hoffman, B.J. (1999) Bile duct stones and laparoscopic cholecystectomy: a decision analysis to assess the roles of intraoperative cholangiography, EUS, and ERCP. Gastrointestinal Endoscopy, 49(3 Pt 1), 334-343 (Mar).
Shimizu, S., Kutsumi, H., Fujimoto, S., and Kawai, K. (1999) Diagnostic endoscopic retrograde cholangiopancreatography. Endoscopy, 31(1), 74-79 (Jan).
Schmalz, M.J., and Geenen, J.E. (1999) Therapeutic pancreatic endoscopy. Endoscopy, 31(1), 88-94 (Jan).
Solana de Lope, J., Aguilera, E., Vinageras Barroso, J., Suarez Moran, E., Garcia Menendez, A., and Perez Manauta, J. (1998) Endoscopic retrograde cholangiopancreatography prior to laparoscopic cholecystectomy in patients with suspected choledocholithiasis. [Article in Spanish] Rev Gastroenterol Mex, 63(2), 77-81 (Apr-Jun).
Can pancreatitis affect the health of a child? My cousin was just diagnosed with pancreatitis, everyone keeps asking themselves why did the Gynecologist not know that she was ill? They did an emergency c-section and the baby is fine, but she is in critical/stable condition. Could this have been caused by the pregnancy?
13th May 1999
Although we are not in a position to comment directly on your cousin's situation - the health care team looking after her are able to do that - the following general comments may be of some help.
Pancreatitis during pregnancy can seriously affect the health of both the fetus and the mother (Chang et al, 1998; Ramin et al, 1995). If clinical signs of distress are detected in the baby that would prompt delivery by Cesarean section.
Diagnosing pancreatitis is not straightforward since similar symptoms can be generated by other disease processes as well, and it is necessary to distinguish between these before appropriate treatment can begin. Ultrasound examination of the abdomen and identification of elevated levels of amylase and lipase (enzymes produced by the pancreas) in the mother's blood are usually sufficient to confirm the diagnosis of pancreatitis.
Most cases of pancreatitis during pregnancy are caused by a bile stone passing down through the bile duct from the gall bladder and obstructing the opening into the duodenum shared with the pancreatic duct. It is unlikely that pregnancy causes pancreatitis - gall stones are usually present in the gall bladder before pregnancy begins - although pregnancy may conceivably influence the timing of the onset of pancreatitis and its subsequent course (Block, and Kelly, T.R. 1989). If the attack of pancreatitis during pregnancy is mild, recovery begins soon after delivery (Chen et al, 1995). If an operation is required to relieve the obstruction, keyhole surgery (endoscopic sphincterotomy) is effective and generally prevents recurrence of pancreatitis (Barthel, Chowdhury, and Miedema, 1998).
References
Barthel, J.S., Chowdhury, T., and Miedema, B.W. (1998) Endoscopic sphincterotomy for the treatment of gallstone pancreatitis during pregnancy. Surgical Endoscopy, 12(5), 394-399 (May).
Bernard, P., Lopez, J.F., Kitmacher, P., Doublier, C., and Peyretou, C. (1990) Acute pancreatitis and pregnancy. A recent case report. [Article in French] J Gynecol Obstet Biol Reprod (Paris), 19(8), 1006-1010.
Block, P., and Kelly, T.R. (1989) Management of gallstone pancreatitis during pregnancy and the postpartum period. Surgical Gynecology and Obstetrics, 168(5), 426-428 (May).
Chang, C.C., Hsieh, Y.Y., Tsai, H.D., Yang, T.C., Yeh, L.S., and Hsu, T.Y. (1998) Acute pancreatitis in pregnancy. Chung Hua I Hsueh Tsa Chih (Taipei), 61(2), 85-92 (Feb).
Chen, C.P., Wang, K.G., Su, T.H., and Yang, Y.C. (1995) Acute pancreatitis in pregnancy. Acta Obstet Gynecol Scand, 74(8), 607-610 (Sep).
Ramin, K.D., Ramin, S.M., Richey, S.D., Cunningham, F.G. (1995) Acute pancreatitis in pregnancy. American Journal of Obstetrics and Gynecology, 173(1), 187-191 (Jul).
Swisher, S.G., Hunt, K.K., Schmit, P.J., Hiyama, D.T., Bennion, R.S., and Thompson, J.E. (1994) Management of pancreatitis complicating pregnancy. American Surgery, 60(10), 759-762 (Oct).
Are there any drugs that could be the cause of pancreatitis, if so what are they?
28th January 2004, edited 15th January 2007
About 2% of all cases of pancreatitis are thought to be drug-induced to some degree (Wilmink and Frick, 1996; Kvande and Madsen, 2001). When ethanol abuse, smoking, and biliary disease are ruled out as aetiologies for pancreatitis, the possibility of drug-induced disease should be investigated (Underwood and Frye, 1993). More than 260 drugs have been implicated so far as possible causes or co-factors in pancreatitis (Battillocchi et al, 2002). The mechanisms suggested for drug-induced pancreatitis include pancreatic duct constriction; immunosuppression; cytotoxic, osmotic, pressure, or metabolic effects; arteriolar thrombosis; direct cellular toxicity; and hepatic involvement. However, much of the evidence so far comes from limited case studies, and clear evidence of an association requires rechallenge tests (in which the suspected drug is given again briefly after recovery from the first occurrence of pancreatitis), consistent case reports, evidence from animal experiments, and data on the incidence of acute pancreatitis during drug trials (Wilmink and Frick, 1996).
The following lists classify drugs and other agents according to published opinions about their degree of possible involvement in pancreatitis. Some agents appear in more than one list, indicating that there are different opinions about the level of association.
Agents reported to have a definite association with pancreatitis:
2',3'-dideoxyinosine (Lankisch, Droge, and Gottesleben, 1995)
asparaginase (Underwood and Frye, 1993)
azathioprine (Underwood and Frye, 1993; Lankisch, Droge, and Gottesleben, 1995; Eland et al, 1999; Andersen, Sonne, and Andersen, 2001)
clomipramine (Andersen, Sonne, and Andersen, 2001)
cimetidine (Eland et al, 1999)
didanosine (Underwood and Frye, 1993)
enalapril (Maringhini et al, 1997)
furosemide, frusemide (Underwood and Frye, 1993; Lankisch, Droge, and Gottesleben, 1995)
hydrochlorothiazide (Lankisch, Droge, and Gottesleben, 1995)
interferon-alpha (Eland et al, 1999)
mercaptopurine (Underwood and Frye, 1993)
mesalazine (Lankisch, Droge, and Gottesleben, 1995; Andersen, Sonne, and Andersen, 2001)
methyldopa (Eland et al, 1999)
metronidazole (Eland et al, 1999)
oestrogens (Underwood and Frye, 1993; Lankisch, Droge, and Gottesleben, 1995)
olsalazine (Eland et al, 1999)
oxyphenbutazon (Eland et al, 1999)
pentamidine (Underwood and Frye, 1993)
rifampicin (Lankisch, Droge, and Gottesleben, 1995)
selective serotonin reuptake inhibitors (SSRIs) (Kvande and Madsen, 2001)
simvastatin (Andersen, Sonne, and Andersen, 2001)
sulfonamides (Underwood and Frye, 1993)
sulindac (Underwood and Frye, 1993)
tetracyclines (Underwood and Frye, 1993)
thiazides (Underwood and Frye, 1993)
valproic acid/valproate (Asconape et al, 1993; Underwood and Frye, 1993; Andersen, Sonne, and Andersen, 2001)
Agents reported to have a probable association with pancreatitis:
allopurinol (Andersen, Sonne, and Andersen, 2001)
angiotensin-converting enzyme inhibitors (Andersen, Sonne, and Andersen, 2001)
antiviral agents used in acquired immunodeficiency syndrome therapy (Andersen, Sonne, and Andersen, 2001)
cimetidine (Underwood and Frye, 1993)
clozapine (Underwood and Frye, 1993)
codeine (Andersen, Sonne, and Andersen, 2001)
corticosteroids (Underwood and Frye, 1993)
didanosine (Andersen, Sonne, and Andersen, 2001)
doxycycline (Eland et al, 1999)
enalapril (Eland et al, 1999)
endoscopic retrograde cholangiopancreatography contrast media (Underwood and Frye, 1993)
famotidine (Eland et al, 1999)
griseofulvin (Andersen, Sonne, and Andersen, 2001)
ibuprofen (Eland et al, 1999)
interferon (Andersen, Sonne, and Andersen, 2001)
lipid-reducing agents (Andersen, Sonne, and Andersen, 2001)
lithium (Andersen, Sonne, and Andersen, 2001)
maprotiline (Eland et al, 1999)
mesalazine (Eland et al, 1999)
methyldopa (Underwood and Frye, 1993)
metronidazole (Underwood and Frye, 1993)
MMR (measles/mumps/rubella) vaccination (Andersen, Sonne, and Andersen, 2001)
oestrogen preparations (Andersen, Sonne, and Andersen, 2001)
paracetamol (Andersen, Sonne, and Andersen, 2001)
salicylates, 5-acetylsalicylic acid agents (Underwood and Frye, 1993; Andersen, Sonne, and Andersen, 2001)
sulindac (Eland et al, 1999)
ticlopine (Andersen, Sonne, and Andersen, 2001)
valproate (Andersen, Sonne, and Andersen, 2001)
zalcitabine (Underwood and Frye, 1993)
Agents reported to have a questionable association with pancreatitis:
(This was edited on 15th January 2007 to remove acetaminophen because it is the same as paracetamol, which is mentioned above and would therefore be a contradiction in terms)
cyclosporine (Underwood and Frye, 1993)
cytarabine (Underwood and Frye, 1993)
erythromycin (Underwood and Frye, 1993)
roxithromycin (Underwood and Frye, 1993)
ketoprofen (Underwood and Frye, 1993)
metolazone (Underwood and Frye, 1993)
octreotide (Underwood and Frye, 1993)
References
Andersen, V., Sonne, J., and Andersen, M. (2001) Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. European Journal of Clinical Pharmacology, 57(6-7), 517-521 (Sep).
Asconape, J.J., Penry, J.K., Dreifuss, F.E., Riela, A., Mirza, W. (1993) Valproate-associated pancreatitis. Epilepsia, 34(1), 177-183 (Jan-Feb).
Battillocchi, B., Diana, M., Dandolo, R., Stefanini, S., D'Amore, L., and Negro, P. (2002) Drug-induced acute pancreatitis: a personal contribution. [Article in Italian] Chirurgia Italiana, 54(5): 605-12 (Sep-Oct).
Eland, I.A., van Puijenbroek, E.P., Sturkenboom, M.J., Wilson, J.H., and Stricker, B.H. (1999) Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands. American Journal of Gastroenterology, 94(9), 2417-2422 (Sep).
Kvande, K.T., and Madsen, S. (2001) Selective serotonin uptake inhibitors and pancreatitis. [Article in Norwegian] Tidsskrift for den Norske Laegeforening, 121(2), 177-178 (Jan 20).
Lankisch, P.G., Droge, M., and Gottesleben, F. (1995) Drug induced acute pancreatitis: incidence and severity. Gut, 37(4), 565-567 (Oct).
Maringhini, A., Termini, A., Patti, R., Ciambra, M., Biffarella, P., and Pagliaro, L. (1997) Enalapril-associated acute pancreatitis: recurrence after rechallenge. American Journal of Gastroenterology, 92(1), 166-167 (Jan).
Underwood TW, Frye CB. (1993) Drug-induced pancreatitis. Clinical Pharmacy, 12(6): 440-448 (Jun).
Wilmink, T., and Frick, T.W. (1996) Drug-induced pancreatitis. Drug Safety, 14(6), 406-423 (Jun).